Johnson & Johnson (JNJ) NewsBite - JNJ Hits 52-Week High
Posted on Tuesday, September 02, 2008 1:32 PM
Johnson & Johnson (NYSE: JNJ) hit a new 52-Week high of $72.06 so far today. Currently the stock is up $1.60 (2.27%) to $72.03 on 8,888,060 shares traded. Today's high is up $10.86 from a 52-Week Low of $61.17. Johnson and Johnson stock has been showing support around $69.77 and resistance in the $71.73 range. Technical indicators for the stock are bullish and S&P gives JNJ a positive 5 STARS (out of 5) strong buy ranking. If you are looking for a hedged play on JNJ the stock seems like it could be a candidate for a September out-of-the-money bull-put credit spread below the 70 range. [ABR-Seven Summits Strategic Investments NewsBite] .
http://www.marketintelligencecenter.com/articles/668693
PharmaMar Recibe el Ok de la FDA Para Iniciar Fase I con PM54 en Combi con Inmuno Para Posible Tratamiento . PARA EI RELEVO DE LURBINECTEDIN ESTABAN PM184 Y PM14 AMBOS RETIRADOS POR LA CIA. AHORA HAY OTROS DOS FÁRMACOS EN FASE I EN EL INTENTO DE RELEVAR A LURBINECTEDIN : PM54 Y PM534 ... EL PROBLEMA ES QUE AMBOS AÚN ESTAN EN FASE I CON TODO LO QUE ESTO IMPLICA EN CUESTIÓN DE PLAZOS ... YA QUE PARA REALUZAR 3 FASES CLÍNICAS HACEN FALTA DE 12 A 15 AÑOS ... NOS IRÍAMOS AL 2040.